Investigation of REcurrence Mechanisms to Adjuvant osimertINib in Radically Resected EGFR-mutated NSCLC Patients

Clinical trial NCT07363252 · RECRUITING

Trial details

NCT number: NCT07363252
Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica
Status: RECRUITING
Study type: OBSERVATIONAL

EGFR-mutated NSCLC

Start date: 2026-04-14
Primary completion: 2028-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.